Cargando…
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
Autores principales: | Tian, Qiu-Ju, Xie, Man, Wang, Ji-Tao, Wang, Yi, Zhang, Bei, Cai, Jin-Zhen, Qi, Xiao-Long, Rao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222404/ https://www.ncbi.nlm.nih.gov/pubmed/35786362 http://dx.doi.org/10.1016/j.hbpd.2022.06.010 |
Ejemplares similares
-
An analysis report on the application of immune checkpoint inhibitors after liver transplantation
por: Xie, Man, et al.
Publicado: (2022) -
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
por: Luo, Xinyi, et al.
Publicado: (2023) -
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
por: Cheung, Ka Shing, et al.
Publicado: (2022) -
Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients
por: Feldman, Amy G., et al.
Publicado: (2023) -
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)